Jasmine Patel Email & Phone Number

New York, New York, United States

• Developed and coordinated multi-disciplinary residency rotation experiences in inpatient and outpatient settings for two PGY2 residents enrolled in the PGY2 hematology/oncology program
• Restructured recruitment processes for 10 residency programs to incorporate diversity, equity, and inclusion as a sitting member of the Residency Advisory Committee at BMC
• Worked with residents to construct local, regional, and national level presentations on emerging oncology topics including novel therapy mechanisms or clinical pearls for targeted therapy
• Identified and developed medication use evaluations, monographs for P&T committee, quality improvement/research projects for residents to meet accreditation standards
• Collaborated with residency program directors of local Boston programs to facilitate discussion of new and emerging data in multiple myeloma and promote inter-institutional relationships

Boston, Massachusetts, United States

• Led clinical outcomes initiatives focused on efficacy and safety outcomes in vulnerable and disparate prostate cancer patients receiving androgen deprivation and novel hormonal therapy
• Worked with the Boston University Medical School grant office to identify and develop grants focused on hematology/oncology disease states
• Led and published a three-year long grant-funded quality improvement initiative in patients with metastatic breast cancer receiving treatment with oral chemotherapy and targeted therapy to minimize delays in treatment.
• Developed and presented a six-part grant-funded accredited international continuing education series on NSCLC treatment highlighting biomarker-driven therapy and multidisciplinary collaboration education
• Created, submitted, and presented a grant-funded continuing education series on cardiovascular considerations in African American patients with prostate cancer receiving treatment with ADT and novel hormonal therapy
• Collaborated in weekly stand-up meetings with nursing, medical, pharmacy, and IT departments to optimize clinic operations and ensure safe IV and oral chemotherapy administration

• Educate all patients newly initiated on oral oncolytic therapy for treatment of various malignancies, including prostate, breast, renal cell, multiple myeloma, chronic myelogenous leukemia, pancreatic, ovarian cancer.
• Perform routine in-clinic and telephone follow-ups on 20 – 30 patients daily as part of the Oral Adherence Program, comprised of ~500 total patients receiving oral oncolytic therapy
• Facilitate approval and initiation of all oral chemotherapy for on-label and off-label indications within outpatient clinics
• Thoroughly review and engage with HCPs on medical information requests in the clinic
• Manage all aspects of Celgene REMS compliance for thalomide, pomalidomide, and lenalidomide
• Coordinate medication delivery for patients on oral oncolytic therapy with various specialty pharmacies, including onsite specialty pharmacy and contracted mail-order pharmacy within the hospital

• Coordinate learning experiences for the PGY-2 hematology/oncology residents for the upcoming residential year
• Work with program preceptors to establish expectations for learning experiences
• Facilitate monthly journal clubs for ongoing literature review

• Provided clinical oversight of two separate rounding teams, consisting of 10 hematology patients and 16 oncology patients
• Coordinated inpatient admissions for chemotherapy administration from the outpatient hematology/oncology clinic
• Tracked monthly high-cost inpatient expenditures such as monoclonal antibodies and growth factors along with cost-savings through hematology/oncology pharmacist stewardship for medications
• Improved inpatient medication reconciliation processes through participation on transitions-of-care focused workgroup
• Maintained and update relevant hospital guidelines, including parenteral iron management and hepatitis B reactivation with anticancer therapy
• Assessed appropriateness of IV chemotherapy based on indication, dosing, toxicity, drug-drug interactions, and pharmacogenomic profile

Greater Boston Area

• The PGY2 oncology pharmacy residency program is an ASHP accredited program that offers a variety of experiences in oncology pharmacy to help fulfill the program purpose. Learning experiences in inpatient, outpatient.

• The PGY1 Pharmacy Residency Program builds on the Doctor of Pharmacy education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a diverse.

Clark, NJ

Newark, NJ

Union, NJ

• Assisting students with thesis development
• Maintaining contact with the professor regarding the student's progress
• Proofreading essays for grammatical appropriateness

Doctor Of Pharmacy (Pharm.D.), Pharmacy

Activities and Societies: Alpha Zeta Omega Pharmaceutical Fraternity, Sigma Sigma Rho Sorority, Incorporated.

Education record